Jun 2, 2026 07:01AM
Jun 2, 2026 07:00AM
Jun 1, 2026 05:00PM
Jun 1, 2026 05:00PM
Jun 1, 2026 12:55AM
May 15, 2026 06:31AM
May 15, 2026 06:30AM Telix Announces Collaborations to Explore PSMA-PET Imaging in Emerging Prostate Cancer Treatment Approaches
Apr 14, 2026 07:05PM
Apr 14, 2026 07:04PM
Apr 10, 2026 06:45AM
Apr 10, 2026 05:30AM
Apr 9, 2026 06:51PM
Apr 6, 2026 07:37PM
Mar 15, 2026 05:25PM Telix Resubmits NDA to U.S. FDA for TLX101-Px (Pixclara®) Brain Cancer Imaging Candidate
Mar 9, 2026 07:20PM
Mar 9, 2026 07:19PM
Feb 27, 2026 07:00AM
Feb 19, 2026 07:02PM
Feb 17, 2026 04:57PM
Feb 17, 2026 04:55PM
Jan 20, 2026 07:00AM Telix Achieves FY 2025 Guidance with US$804M (A$1.2B) Revenue, Accelerates Growth with Gozellix Launch
Jan 16, 2026 02:20PM
Jan 16, 2026 02:19PM
Dec 21, 2025 04:38PM
Dec 21, 2025 04:38PM
Dec 10, 2025 07:00AM
Dec 10, 2025 07:00AM
Nov 19, 2025 02:00PM ZIRCON-X Analysis: TLX250-CDx Impacts Clinical Decision Making for Almost Half of Patients with Indeterminate Renal Masses
Oct 23, 2025 07:03AM
Oct 23, 2025 07:00AM
Oct 14, 2025 02:22AM
Sep 23, 2025 10:15AM
Sep 23, 2025 10:15AM
Sep 9, 2025 07:00PM
Sep 9, 2025 07:00PM Telix Doses First Patient in Phase 3 BiPASS Trial: PSMA-PET Imaging for Prostate Cancer Diagnosis
Jul 22, 2025 04:06AM
Jul 9, 2025 06:45PM
Jul 3, 2025 06:37AM
Jun 23, 2025 07:15AM
Jun 20, 2025 08:00AM
Jun 11, 2025 07:00AM
Jun 3, 2025 06:57AM Telix Investor Day in New York City on June 11, 2025: Presenting KOLs
Apr 28, 2025 06:30PM
Apr 22, 2025 04:17AM
Apr 15, 2025 06:37PM
Apr 8, 2025 06:30AM
Apr 1, 2025 08:49AM
Mar 21, 2025 06:35AM
Mar 21, 2025 06:30AM FDA Approves New Prostate Cancer Imaging Agent Gozellix®
Mar 17, 2025 05:53PM

322,203 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All